ClinicalTrials.Veeva

Menu

Contrast Induced Acute Kidney in Patients With Acute Stroke

N

Nanjing Medical University

Status

Unknown

Conditions

Stroke, Acute

Treatments

Drug: Radiopaque Media

Study type

Observational

Funder types

Other

Identifiers

NCT03132558
AISAKI001

Details and patient eligibility

About

Computed tomographic angiography (CTA) is recommended for identifying eligible patient with acute ischemic stroke (AIS) to receieve endovascular treatment. We are going to conduct this prospective corhot study to observe if sequential use contrast in CTA examination and in endovascular treatment will cause acute kidney injury.

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients who are suspected with AIS.
  • Non-contrast head CT excludes intracranial hemorrhage.

Exclusion criteria

  • Lacking of pre-CTA Creatinine
  • Lacking of post-angiography Creatinine with 24-48 hours

Trial design

200 participants in 2 patient groups

CTA
Description:
Patients with AIS only receieved cerebral CTA exam.
Treatment:
Drug: Radiopaque Media
CTA+DSA
Description:
Patients with AIS receieved cerebral CTA, followed by endovascular treatment with the guidence of digital substration angiography (DSA).
Treatment:
Drug: Radiopaque Media

Trial contacts and locations

1

Loading...

Central trial contact

HaiBin Shi, MD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems